http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2620702-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c9faa155d463b43beea07486b35df63 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-021 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6491 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 |
| filingDate | 2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b8e477b22072633fd4add9299779952 |
| publicationDate | 2017-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2620702-B2 |
| titleOfInvention | Gene construction and its use in the treatment of cardiac fibrosis |
| abstract | Gene construction and its use in the treatment of cardiac fibrosis. # The present invention relates to a new gene construction comprising a) a DNA sequence encoding the proMMP2 protein, b) a DNA sequence encoding the promoter of MHC- {be}, operably linked to sequence a), and c) a protein expression and secretion vector that operably binds sequences a) and b). Likewise, a pharmaceutical composition, comprising said gene construct, is contemplated for use in the treatment of cardiac fibrosis. Finally, the method for obtaining the gene construct of the invention is contemplated. |
| priorityDate | 2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 189.